Literature DB >> 28622163

Novel roles for mucin 1 in the kidney.

Mohammad M Al-Bataineh1, Timothy A Sutton, Rebecca P Hughey.   

Abstract

PURPOSE OF REVIEW: Recent studies in the kidney have revealed that the well characterized tumor antigen mucin 1 (MUC1/Muc1) also has numerous functions in the normal and injured kidney. RECENT
FINDINGS: Mucin 1 is a transmembrane mucin with a robust glycan-dependent apical targeting signal and efficient recycling from endosomes. It was recently reported that the TRPV5 calcium channel is stabilized on the cell surface by galectin-dependent cross-linking to mucin 1, providing a novel mechanism for regulation of ion channels and normal electrolyte balance.Our recent studies in mice show that Muc 1 is induced after ischemia, stabilizing hypoxia-inducible factor 1 (HIF-1)α and β-catenin levels, and transactivating the HIF-1 and β-catenin protective pathways. However, prolonged induction of either pathway in the injured kidney can proceed from apparent full recovery to chronic kidney disease. A very recent report indicates that aberrant activation of mucin 1 signaling after ischemic injury in mice and humans is associated with development of chronic kidney disease and fibrosis. A frameshift mutation in MUC1 was recently identified as the genetic lesion causing medullary cystic kidney disease type 1, now appropriately renamed MUC1 Kidney Disease.
SUMMARY: Studies of mucin 1 in the kidney now reveal significant functions for the extracellular mucin-like domain and signaling through the cytoplasmic tail.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28622163      PMCID: PMC5786376          DOI: 10.1097/MNH.0000000000000350

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  68 in total

1.  Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis.

Authors:  R L Ceriani; C M Chan; F S Baratta; L Ozzello; C M DeRosa; D V Habif
Journal:  Int J Cancer       Date:  1992-05-28       Impact factor: 7.396

2.  Cloning, expression, and purification of galectins for in vitro studies.

Authors:  Paul A Poland; Carol L Kinlough; Rebecca P Hughey
Journal:  Methods Mol Biol       Date:  2015

3.  Epithelial membrane antigen in normal and proteinuric glomeruli and in damaged proximal tubules.

Authors:  A J Howie
Journal:  J Pathol       Date:  1986-01       Impact factor: 7.996

4.  Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury.

Authors:  Gunnar Schley; Bernd Klanke; Johannes Schödel; Frauke Forstreuter; Deepa Shukla; Armin Kurtz; Kerstin Amann; Michael S Wiesener; Seymour Rosen; Kai-Uwe Eckardt; Patrick H Maxwell; Carsten Willam
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

5.  The cell surface mucin MUC1 limits the severity of influenza A virus infection.

Authors:  J L McAuley; L Corcilius; H-X Tan; R J Payne; M A McGuckin; L E Brown
Journal:  Mucosal Immunol       Date:  2017-03-22       Impact factor: 7.313

6.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase.

Authors:  Erik P Lillehoj; Hakryul Kim; Ellen Y Chun; K Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-06-25       Impact factor: 5.464

8.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.

Authors:  M Teresa Grande; Berta Sánchez-Laorden; Cristina López-Blau; Cristina A De Frutos; Agnès Boutet; Miguel Arévalo; R Grant Rowe; Stephen J Weiss; José M López-Novoa; M Angela Nieto
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

9.  Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development.

Authors:  V M Braga; L F Pemberton; T Duhig; S J Gendler
Journal:  Development       Date:  1992-06       Impact factor: 6.868

10.  MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.

Authors:  Sara K Lindén; Yong H Sheng; Alison L Every; Kim M Miles; Emma C Skoog; Timothy H J Florin; Philip Sutton; Michael A McGuckin
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more
  6 in total

1.  MUC1 Makes Me Miserable.

Authors:  Daniel P Gale; Robert Kleta
Journal:  J Am Soc Nephrol       Date:  2018-08-17       Impact factor: 10.121

Review 2.  Glycocalyx Curving the Membrane: Forces Emerging from the Cell Exterior.

Authors:  Joe Chin-Hun Kuo; Matthew J Paszek
Journal:  Annu Rev Cell Dev Biol       Date:  2021-10-06       Impact factor: 13.827

3.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

4.  Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.

Authors:  Hee-Sung Ahn; Jong Ho Kim; Hwangkyo Jeong; Jiyoung Yu; Jeonghun Yeom; Sang Heon Song; Sang Soo Kim; In Joo Kim; Kyunggon Kim
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

Review 5.  Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research.

Authors:  Zhidong Wang; Yu J Cao
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

6.  Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review.

Authors:  Zuoyu Liang; Ping Zhou; Yuxuan Wang; Ying Zhang; Dan Li; Xiaoxing Su; Yu Fan; Yuan Tang; Lili Jiang; Weiya Wang
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.